Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22228634 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: cytarabine;   Drug: etoposide phosphate;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: temozolomide

Study has passed its completion date and status has not been verified in more than two years.